Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 22Unknown 11Recruiting 9Active not recruiting 8Terminated 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Sarcoma 1Fibrosarcoma 1Choroid Plexus Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Interventional × Dactinomycin × Clear all
NCT01014767 2019-08-20

Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors

Tufts Medical Center

Phase 3 Terminated
27 enrolled 1 chart
CNS

Brain Neoplasms, Choroid Plexus Neoplasms

NCT00072280 2014-09-30

Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma

Children's Oncology Group

Phase 2 Terminated
7 enrolled 9 charts
Sarcoma

Fibrosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡